NCT02008357 Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Status COMPLETED Phase PHASE3
NCT01760005 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3